By a biology built to keep you eating. This is the story of the loop you have been living in — and the doctor-led way out of it.
Free 2-minute check · Provider review required · No prescription is guaranteed · Results vary
You ate a careful dinner. You did everything right today. And still — here you are, in the cold light of the refrigerator, negotiating.
The thinking about food never switches off. Researchers call it food noise. You call it every single evening.
Plus the shame nobody invoices you for.
Illustrative ranges of typical consumer spending. Your numbers may differ.
“This is who I am.” You have carried that verdict the way you carry a coat in summer — quietly, constantly, ashamed of the weight of it.
Here is what the verdict never accounted for: when you lose weight by willpower alone, your hormones push back harder. Hunger signaling rises. Fullness signaling falls. Your biology defends the weight it knows — and it does not care how motivated you are.
You didn't fail 9 diets.
9 diets failed to treat the actual problem.
GLP-1 is one of the gut-brain hormones that regulate fullness and cravings — the signal that says enough. GLP-1 medications amplify that signal. Not your discipline. The signal.
Appetite receptors in the brain are activated, and the constant background argument fades. You think about food when it is time to eat — not all day.
Gastric emptying slows, so fullness stays with you. Smaller portions stop feeling like punishment — because you are genuinely not hungry.
Insulin response evens out, smoothing the spikes and crashes that drive cravings at 3 PM and again at 9.
Taken consistently under medical supervision, the signal keeps working — so the plan can hold, too. That is the difference between a diet and a treatment.
How strongly people respond varies. A licensed provider determines whether treatment is appropriate for you.
Average body-weight reduction with semaglutide over 68 weeks, in the STEP-1 clinical trial.*
With tirzepatide at the highest dose over 72 weeks, in the SURMOUNT-1 clinical trial.*
*STEP-1: Wilding et al., NEJM 2021. SURMOUNT-1: Jastreboff et al., NEJM 2022. Group averages from trials of FDA-approved branded medications, taken alongside lifestyle changes under medical supervision. They are not a promise of individual results and do not describe compounded products. Individual results vary.
That is not weakness.
That is chemistry.
The relief is not losing the hunger. It is losing the shame that came with it.
Free 2-minute check · Provider review required · No prescription is guaranteed · Results vary
Before anything is prescribed, a U.S.-licensed provider reviews your health history, your medications, and your goals — then tells you straight whether GLP-1 treatment is appropriate for you.
Not everyone qualifies. That is by design.
“Most of my patients spent twenty years believing they were the failure. They were not. The signal was.”
— Dr. John Bernard, Board-Certified Physician · independent medical care team serving MedicLab membersA private online intake about your health, history, and goals. No waiting room. No part of it requires you to perform your shame for a stranger.
A U.S.-licensed clinician evaluates whether treatment is medically appropriate for you — and which medication and format fit. You get a straight answer either way.
Your medication is prepared by a state-licensed U.S. pharmacy and arrives in discreet, cold-chain packaging. Check-ins, dose adjustments, and unlimited care messaging continue after the box arrives.
Pharmacy processing typically 1–3 business days after approval · Shipping 3–7 business days · If you are not approved, the medication portion of your payment is refunded.
The people who quit GLP-1 programs usually quit at a plateau, in silence, convinced it stopped working. The medication may be fine — but the care ended at checkout.
MedicLab connects the medication to a complete system of care from independent licensed providers — built so month 4 is treated as seriously as day 1. You are never left alone with a vial and a guess.
From-$199 plans use compounded medication, which is not FDA-approved — see the disclosure in Chapter 07. Final cost may vary based on provider review, dosage, pharmacy availability, shipping and applicable fees. *HSA/FSA eligibility depends on your plan and applicable law.
Free 2-minute check first. Payment only if prescribed — a licensed provider must determine treatment is clinically appropriate. No prescription is guaranteed.
Semaglutide — the GLP-1 signal, turned up. Tirzepatide — the dual-pathway option, acting on GLP-1 and GIP. Each comes as a weekly injection or a daily tablet, prepared for your prescribed dose by a state-licensed U.S. pharmacy.
Which molecule, which format, which dose — that is your provider's call, made with you, after reading your story.
Every plan below includes everything in TotalCare — the price varies only by molecule and format.
Weekly GLP-1 injection for appetite control, with B12 or Glycine.
Check eligibility →Daily needle-free tablet with added Vitamin B6.
Check eligibility →Weekly dual-pathway GLP-1/GIP injection, with B12 or Glycine.
Check eligibility →Daily dual-pathway tablet, dosed 4mg to 20mg.
Check eligibility →Provider review required · No prescription is guaranteed · Results vary
Prefer brand-name pens? Ozempic®, Wegovy®, Mounjaro® and Zepbound® are available at $1,499/mo — including provider consultations, dose management, and cold-chain shipping. FDA-approved medication, dispensed by a licensed pharmacy, if your provider prescribes it.
Check eligibility for brand pens“The format — pen or tablet — is the packaging.
The medicine inside is the product.”
Needle fear is a fair concern, not a weakness. The needles are fine and short — and many people find the reality far milder than the anticipation. If not, the tablets exist for a reason. Your provider matches the format to you.
Our from-$199 plans use compounded semaglutide or tirzepatide prepared by state-licensed U.S. pharmacies. Compounded medications are not FDA-approved and are not the same as Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. Brand-name pens we offer are FDA-approved. Your provider discusses which option is right for you.
GLP-1 medications can cause side effects, including nausea, vomiting, diarrhea, and constipation — most are gastrointestinal and dose-dependent — and, rarely, more serious conditions such as pancreatitis or gallbladder disease. Your provider walks you through risks and benefits before you start, and the Side-Effect Playbook is included with every plan.
Here is the part most pages skip. We publish reviews only from real, consenting members — never fabricated, never incentivized, never borrowed from somewhere else.
As a young telehealth platform, we would rather show you an honest empty slot than a stranger's stock photo with a made-up name. What we can show you today: the peer-reviewed trial data above, the licensed clinicians who review every intake, and a promise with our name on it below.
Reserved for a verified member story — shared with consent, or not at all.
Verified & consented onlyWhen a member shares a result, you will read it here — name, consent, and all.
Never fabricatedThis slot is empty today. Six months from now, the story in it could be yours.
Never borrowedFollow your provider-guided plan for six months — stay active and complete your check-ins. If you have not made meaningful progress toward your documented goal, you receive a complimentary, full Progress Review: a plan audit, nutrition review, coaching adjustment, and provider escalation when clinically appropriate. We would rather fix the plan than argue about it.
A clinical commitment — not a guarantee of pounds, percentages, or timeframes. Individual results vary. Promise terms apply — request the full terms before you enroll: hello@mediclab.us
If the provider does not approve a prescription, the medication portion of your order is automatically refunded — and the 2-minute check itself is free.
No phone maze, no games, no guilt-trips. Manage everything from your patient portal.
One transparent monthly price, with no surprise add-ons. HSA/FSA eligible.*
The goal was never really a number. It is quiet. It is thinking about food only when it is time to eat. It is putting the verdict down.
The check takes two minutes. The answer is honest either way. The only thing you stand to lose today is the loop.
Provider review required · No prescription is guaranteed · Results vary
Not ready today? Get the free Side-Effect Playbook by email — or ask us anything: hello@mediclab.us
Honestly: not everyone does — and that is by design. A U.S.-licensed provider reviews your health history, current medications, BMI and goals, then tells you straight whether GLP-1 treatment is appropriate for you. Payment never guarantees a prescription.
If you are not approved, the medication portion of your payment is automatically refunded.
No. Our from-$199 plans use compounded semaglutide or tirzepatide prepared by state-licensed U.S. pharmacies. Compounded medications are not FDA-approved and are not the same as Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. We also offer those FDA-approved brand-name pens at $1,499/mo, dispensed by a licensed pharmacy. Your provider discusses which option fits you.
GLP-1 medications can cause nausea, vomiting, diarrhea, and constipation — most effects are gastrointestinal and tend to follow dose increases. Rarely, more serious conditions such as pancreatitis or gallbladder disease can occur. Your provider reviews risks and benefits with you before you start, your dose is adjusted personally, and every plan includes the Side-Effect Playbook.
Yes. Both semaglutide and tirzepatide come as daily tablets. And if you are open to it: injection needles are fine and short, and many people find the reality far milder than the anticipation. Needle fear is a fair concern, not a weakness — your provider matches the format to you.
A plateau in month three is not failure — it is a signal that the plan may need a check-in, not abandonment. Your plan includes plateau reviews: dose evaluation, nutrition review, and provider escalation when clinically appropriate. Plateaus become checkpoints, not exits.
Plans start at $199/mo for compounded semaglutide injections, up to $299/mo for tirzepatide tablets — including provider consultations, dose adjustments, unlimited care messaging, free express cold-chain shipping, and the bonus guides. Our brand-name pen plan is $1,499/mo including the same care; for comparison, pharmacy cash prices for the medication alone typically run ~$1,000–$1,350/mo.
No insurance needed. No membership fee. Final cost may vary based on provider review, dosage, pharmacy availability, shipping and applicable fees. *HSA/FSA eligibility depends on your plan and applicable law.
You can cancel anytime, yourself, online, from your patient portal — before any renewal. Note that ongoing refills always depend on your provider confirming continued clinical eligibility; subscription billing never guarantees a prescription or refill.
Yes. Your intake and care messaging are HIPAA-secure, and medication ships in discreet, unmarked cold-chain packaging. No waiting rooms, no pharmacy counters — no part of this requires you to perform your story for a stranger.
Objections answered? The check still takes two minutes.
Start my 2-minute check →Free 2-minute check · Provider review required · No prescription is guaranteed · Results vary